Product code OUR— Orthopedic

IFUSE IMPLANT SYSTEM

Classification name
Sacroiliac Joint Fixation
Device class
Class 2
Regulation
21 CFR 888.3040
Advisory panel
Orthopedic
Total cleared
132
First cleared
Most recent

FDA classification definition

“sacroiliac joint fusion”

— U.S. Food and Drug Administration, device classification record for product code OUR under 21 CFR 888.3040, via openFDA

Market context for product code OUR

FDA has cleared 132 devices under product code OUR between 2005 and 2026, filed by 63 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Clearances per year

last 15 years

Top applicants under product code OUR

Adverse events under product code OUR

product code OUR
Death
3
Injury
347
Total
350

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Recent clearances under product code OUR

1–100 of 132

Data sourced from openFDA. This site is unofficial and independent of the FDA.